RecruitingNot ApplicableNCT07466966

Minimally-Invasive Non-Surgical Therapy of Peri-Implantitis

Minimally-Invasive Non-Surgical Therapy of Peri-Implantitis: A Multicenter Randomized Controlled Trial (MINST vs NSPT)


Sponsor

St. Anne's University Hospital Brno, Czech Republic

Enrollment

106 participants

Start Date

Jan 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This multicenter, single-masked randomized controlled clinical trial evaluates the effectiveness of minimally-invasive non-surgical therapy (MINST) compared with standard non-surgical peri-implant therapy (NSPT) in patients diagnosed with peri-implantitis. The study investigates clinical outcomes, radiographic bone levels, patient-reported outcomes, and treatment time over 12 months.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Age ≥18
  • Peri-implantitis diagnosis (PPD \>6 mm, BOP+, bone loss ≥3 mm)
  • Accessible implant surface without removing suprastructure
  • FMPS \<30%, FMBS \<30-35%

Exclusion Criteria8

  • Antibiotics in last 3 months
  • Pregnancy/lactation
  • Uncontrolled diabetes (HbA1c ≥7)
  • Long-term SPIC (\>2 years)
  • Previous implant therapy \<12 months
  • Smoking/vaping in last 12 months
  • Hopeless implant
  • Need for adjunctive antibiotics

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURENon-Surgical Peri-implant Therapy (NSPT)

Standard mechanical debridement of the peri-implant pocket performed under local anesthesia. Treatment includes supra- and submucosal ultrasonic debridement using stainless-steel ultrasonic tips, followed by mechanical curettage of granulation tissue with steel curettes (Columbia 4R/4L). Soft-tissue curettage is performed from the inner aspect of the peri-implant pocket. No time restriction is imposed; the operator works until the implant surface is clinically clean.

PROCEDUREMinimally-Invasive Non-Surgical Therapy (MINST)

Minimally invasive ultrasonic debridement performed under local anesthesia using exclusively thin, non-diamond ultrasonic tips (Satalec PS3, EMS PS, PS, PL1, PL2; Siroperio 1/2/3/7; Woodpecker P3; Acteon 10Z). Treatment is carried out under ≥3× magnification with emphasis on tissue preservation. The operator aims to achieve a stable blood clot emerging from the peri-implant pocket after instrumentation. No curettes or sharp instruments are used.


Locations(1)

Syndenta s.r.o., Hlinky 92, 603 00 Brno, Czech Republic

Brno, Czechia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07466966


Related Trials